US 11135172
Rifabutin-based compositions and methods for treating Helicobacter pylori infection
granted A61KA61K31/395A61K31/43
Quick answer
US patent 11135172 (Rifabutin-based compositions and methods for treating Helicobacter pylori infection) held by RedHill Biopharma Ltd. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/395, A61K31/43, A61K31/435, A61K31/438